Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Rivastigmine for vascular cognitive impairment.

Birks J, McGuinness B, Craig D.

Cochrane Database Syst Rev. 2013 May 31;(5):CD004744. doi: 10.1002/14651858.CD004744.pub3. Review.

PMID:
23728651
2.

Galantamine for vascular cognitive impairment.

Birks J, Craig D.

Cochrane Database Syst Rev. 2006 Jan 25;(4):CD004746. doi: 10.1002/14651858.CD004746.pub2. Review.

PMID:
23862185
3.

Rivastigmine for Alzheimer's disease.

Birks JS, Grimley Evans J.

Cochrane Database Syst Rev. 2015 Apr 10;(4):CD001191. doi: 10.1002/14651858.CD001191.pub3. Review.

PMID:
25858345
4.

Rivastigmine for vascular cognitive impairment.

Craig D, Birks J.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004744. Review. Update in: Cochrane Database Syst Rev. 2013;5:CD004744.

PMID:
15846730
5.

Rivastigmine for Alzheimer's disease.

Birks JS, Chong LY, Grimley Evans J.

Cochrane Database Syst Rev. 2015 Sep 22;9:CD001191. [Epub ahead of print] Review.

PMID:
26393402
6.

Rivastigmine for Alzheimer's disease.

Birks J, Grimley Evans J, Iakovidou V, Tsolaki M, Holt FE.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001191. doi: 10.1002/14651858.CD001191.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;4:CD001191.

PMID:
19370562
7.

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Rolinski M, Fox C, Maidment I, McShane R.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Review.

PMID:
22419314
8.

Donepezil for vascular cognitive impairment.

Malouf R, Birks J.

Cochrane Database Syst Rev. 2004;(1):CD004395. Review.

PMID:
14974068
9.

Cholinesterase inhibitors for Alzheimer's disease.

Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593. Review.

10.

Cholinesterase inhibitors for rarer dementias associated with neurological conditions.

Li Y, Hai S, Zhou Y, Dong BR.

Cochrane Database Syst Rev. 2015 Mar 3;(3):CD009444. doi: 10.1002/14651858.CD009444.pub3. Review.

PMID:
25734590
11.

Galantamine for vascular cognitive impairment.

Craig D, Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004746. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD004746.

PMID:
16437493
12.

Donepezil for dementia due to Alzheimer's disease.

Birks J, Harvey RJ.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001190. Review.

PMID:
16437430
13.

Pharmacotherapy for chronic cognitive impairment in traumatic brain injury.

Dougall D, Poole N, Agrawal N.

Cochrane Database Syst Rev. 2015 Dec 1;(12):CD009221. doi: 10.1002/14651858.CD009221.pub2. Review.

PMID:
26624881
14.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747.

PMID:
11687119
15.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2002;(3):CD001747. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD001747.

PMID:
12137632
16.

Metrifonate for Alzheimer's disease.

López-Arrieta JM, Schneider L.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003155. Review.

PMID:
16625573
17.

Cholinesterase inhibitors for dementia with Lewy bodies.

Wild R, Pettit T, Burns A.

Cochrane Database Syst Rev. 2003;(3):CD003672. Review.

PMID:
12917981
18.

Folic acid with or without vitamin B12 for cognition and dementia.

Malouf M, Grimley EJ, Areosa SA.

Cochrane Database Syst Rev. 2003;(4):CD004514. Review. Update in: Cochrane Database Syst Rev. 2008;(4):CD004514.

PMID:
14584018
19.

Rivastigmine for Alzheimer's disease.

Birks J, Grimley Evans J, Iakovidou V, Tsolaki M.

Cochrane Database Syst Rev. 2000;(4):CD001191. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD001191.

PMID:
11034705
20.

Donepezil for dementia due to Alzheimer's disease.

Birks JS, Harvey R.

Cochrane Database Syst Rev. 2003;(3):CD001190. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD001190.

PMID:
12917900
Items per page

Supplemental Content

Support Center